Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3136 AL 3150

The search for Alzheimer disease therapeutics - same targets, better trials?

Rafii MS, Aisen PS.

Nat Rev Neurol. 2020 Nov;16(11):597-598. doi: 10.1038/s41582-020-00414-3.

Linking the Mini-Mental State Examination, the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil

Levine SZ, Yoshida K, Goldberg Y, Samara M, Cipriani A, Efthimiou O, Iwatsubo T, Leucht S, Furukawa TA.

Evid Based Ment Health. 2021 May;24(2):56-61. doi: 10.1136/ebmental-2020-300184. Epub 2020 Oct 6.

Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer's disease

Angrist M, Yang A, Kantor B, Chiba-Falek O.

Life Sci Soc Policy. 2020 Oct 12;16(1):11. doi: 10.1186/s40504-020-00106-2.

Antidiabetic Drugs in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review

Muñoz-Jiménez M, Zaarkti A, García-Arnés JA, García-Casares N.

Dement Geriatr Cogn Disord. 2020;49(5):423-434. doi: 10.1159/000510677. Epub 2020 Oct 20.

Diagnosis Test Meta-Analysis for Apolipoprotein E in Alzheimer's Disease

Xiong X, Xiao H, Zhang Y, Yu D, Chuan J, Zhong L, Yin Q, Tong R.

Dis Markers. 2020 Oct 9;2020:6486031. doi: 10.1155/2020/6486031. eCollection 2020.

Vitamins in Alzheimer's Disease-Review of the Latest Reports

Mielech A, Puścion-Jakubik A, Markiewicz-Żukowska R, Socha K.

Nutrients. 2020 Nov 11;12(11):3458. doi: 10.3390/nu12113458.

The positive effect of spermidine in older adults suffering from dementia : First results of a 3-month trial

Pekar T, Bruckner K, Pauschenwein-Frantsich S, Gschaider A, Oppliger M, Willesberger J, Ungersbäck P, Wendzel A, Kremer A, Flak W, Wantke F, Jarisch R.

Wien Klin Wochenschr. 2021 May;133(9-10):484-491. doi: 10.1007/s00508-020-01758-y. Epub 2020 Nov 19.

Recent Advances in Nanotechnology: A Novel Therapeutic System for the Treatment of Alzheimer's Disease

Chauhan PS, Yadav D, Koul B, Mohanta YK, Jin JO.

Curr Drug Metab. 2020;21(14):1144-1151. doi: 10.2174/1389200221666201124140518.

BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain

Sur C, Kost J, Scott D, Adamczuk K, Fox NC, Cummings JL, Tariot PN, Aisen PS, Vellas B, Voss T, Mahoney E, Mukai Y, Kennedy ME, Lines C, Michelson D, Egan MF.

Brain. 2020 Dec 1;143(12):3816-3826. doi: 10.1093/brain/awaa332.

Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology

Shabbir U, Rubab M, Tyagi A, Oh DH.

Int J Mol Sci. 2020 Dec 27;22(1):196. doi: 10.3390/ijms22010196.

Psychotropic Medication and Cognitive, Functional, and Neuropsychiatric Outcomes in Alzheimer's Disease (AD)

Oh ES, Rosenberg PB, Rattinger GB, Stuart EA, Lyketsos CG, Leoutsakos JS.

J Am Geriatr Soc. 2021 Apr;69(4):955-963. doi: 10.1111/jgs.16970. Epub 2020 Dec 31.

Rhizoma Coptidis for Alzheimer's Disease and Vascular Dementia: A Literature Review

Wang Z, Yang Y, Liu M, Wei Y, Liu J, Pei H, Li H.

Curr Vasc Pharmacol. 2020;18(4):358-368. doi: 10.2174/1570161117666190710151545.

Is Ongoing Anticholinergic Burden Associated With Greater Cognitive Decline and Dementia Severity in Mild to Moderate Alzheimer's Disease?

Dyer AH, Murphy C, Segurado R, Lawlor B, Kennelly SP; NILVAD Study Group.

J Gerontol A Biol Sci Med Sci. 2020 Apr 17;75(5):987-994. doi: 10.1093/gerona/glz244.

A Pilot Study Comparing Effects of Bifrontal Versus Bitemporal Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Mild Alzheimer Disease

Liu CS, Herrmann N, Gallagher D, Rajji TK, Kiss A, Vieira D, Lanctôt KL.

J ECT. 2020 Sep;36(3):211-215. doi: 10.1097/YCT.0000000000000639.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias